Charles River Newsroom

Mizuho Securities Maintains Charles River(CRL.US) With Hold Rating, Announces Target Price $210

Futu NewsSep 18 04:31

Mizuho Securities Maintains Charles River(CRL.US) With Hold Rating

Futu NewsAug 14 01:31

Hold Rating on Charles River Labs Amidst Pharma Restructuring and Uncertain Near-Term Earnings

TipRanksAug 14 01:00

Mizuho Adjusts Price Target on Charles River Laboratories International to $210 From $235, Maintains Neutral Rating

MT NewswiresAug 13 17:54

Charles River Analyst Ratings

BenzingaAug 12 23:02

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Charles River Labs (CRL) and Akero Therapeutics (AKRO)

TipRanksAug 12 18:37

Baird Cuts Charles River Labs to Neutral, Cites Lagging Recovery

Seeking AlphaAug 9 03:05

Charles River Analyst Ratings

BenzingaAug 9 02:49

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $250 From $290

MT NewswiresAug 8 22:13

Evercore ISI Group Maintains Outperform on Charles River, Lowers Price Target to $225

BenzingaAug 8 21:06

Barclays Keeps Their Hold Rating on Charles River Labs (CRL)

TipRanksAug 8 20:25

Charles River Labs Price Target Cut to $191.00/Share From $239.00 by Baird

Dow JonesAug 8 17:33

Charles River Analyst Ratings

BenzingaAug 8 17:27

Baird Downgrades Charles River to Neutral, Lowers Price Target to $191

BenzingaAug 8 17:26

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $240 From $300

MT NewswiresAug 7 23:55

Stephens Adjusts Price Target on Charles River Laboratories International to $250 From $280

MT NewswiresJul 16 21:10

Baird Adjusts Price Target on Charles River Laboratories International to $239 From $271

MT NewswiresJul 10 21:27

Baird Maintains Outperform on Charles River, Lowers Price Target to $239

BenzingaJul 10 20:16

Charles River Analyst Ratings

BenzingaJul 10 20:15

Charles River Analyst Ratings

BenzingaJun 28 20:22